Neither the U.S. Securities
and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the securities
or passed upon the accuracy or the adequacy of this document, the accompanying prospectus, prospectus supplement or underlying
supplements. Any representation to the contrary is a criminal offense. We have appointed HSBC Securities (USA) Inc., an affiliate
of ours, as the agent for the sale of the securities. HSBC Securities (USA) Inc. will purchase the securities from us for distribution
to other registered broker-dealers or will offer the securities directly to investors. In addition, HSBC Securities (USA) Inc.
or another of its affiliates or agents may use the pricing supplement to which this free writing prospectus relates in market-making
transactions in any securities after their initial sale. Unless we or our agent informs you otherwise in the confirmation of sale,
the pricing supplement to which this free writing prospectus relates is being used in a market-making transaction. See “Supplemental
Plan of Distribution (Conflicts of Interest)” on page FWP-16 of this free writing prospectus.
Indicative Terms*
Principal Amount
|
$1,000 per security
|
Term
|
Approximately 3 years
|
Upside
Participation Rate
|
200% (2x) exposure to any positive Reference Return, subject to the relevant Maximum Cap
|
Buffer Value
|
With respect to each offering, -10%
|
Payment at
Maturity
per security
|
If the relevant underlying Reference Return is
greater than zero
, you will receive the lesser of:
a) $1,000 + ($1,000 ×
Reference Return × Upside Participation Rate); and
b) $1,000 + ($1,000 × Maximum Cap).
If the relevant Reference Return is less than
or equal to zero but greater than or equal to the Buffer Value:
$1,000 (zero return).
If the relevant Reference Return is less than
the relevant Buffer Value:
$1,000 + ($1,000 × (Reference Return + 10%)). For example,
if the Reference Return is -30%, you will suffer a 20% loss and receive 80% of the Principal Amount, subject to the credit risk
of HSBC. If the Reference Return is less than the relevant Buffer Value, you will lose up to 90% of your investment.
|
Reference Return
|
Final Value – Initial Value
Initial Value
|
Initial Value
|
The Official Closing Level of the relevant Reference Asset on the Pricing Date.
|
Final Value
|
The Official Closing Level of such Reference Asset on the Final Valuation Date.
|
Pricing Date
|
April 19, 2013
|
Trade Date
|
April 19, 2013
|
Original Issue Date
|
April 26, 2013
|
Final Valuation Date
|
April 19, 2016
|
Maturity Date
|
April 26, 2016
|
* As more fully described beginning
on page FWP-4.
The Buffered AMPS
TM
For
investors who seek a particular Market Exposure and who believe the corresponding Reference Asset will appreciate over the term
of the Buffered AMPS, the Buffered AMPS provide an opportunity for accelerated returns (subject to a Maximum Cap). If the Reference
Return is below the Buffer Value, then the Buffered AMPS provide 1:1 exposure to any potential decline in the relevant Reference
Asset beyond -10%.
If
the relevant Reference Asset appreciates over the term of the securities, you will realize 200% (2x) of the relevant Reference
Asset appreciation up to the relevant Maximum Cap. If the relevant Reference Asset declines, you will lose 1% of your investment
for every 1% decline in the relevant Reference Asset beyond the -10% Buffer Value.
The
offering period for the Buffered AMPS is through
April 19, 2013
|
Payoff Example
The table at right shows the hypothetical payout profile of an investment in the securities reflecting the 200% (2x) Upside Participation Rate and assuming a 25% Maximum Cap. The actual Maximum Cap with respect to your Buffered AMPS will be determined on the Pricing Date.
|
|
The EURO STOXX 50
®
Index
|
|
The Russell 2000
®
Index
|
The SX5E is composed of 50 stocks from
the Eurozone (Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, the Netherlands, Portugal and Spain)
portion of the STOXX Europe 600 Supersector indices. The STOXX Europe 600 Supersector indices contain the 600 largest stocks traded
on the major exchanges of 18 European countries and are organized into the following 19 Supersectors: automobiles & parts;
banks; basic resources; chemicals; construction & materials; financial services; food & beverage; health care; industrial
goods & services; insurance; media; oil & gas; personal & household goods; real estate; retail; technology; telecommunications;
travel & leisure and utilities.
|
|
The RTY is designed to track
the performance of the small-capitalization segment of the U.S. equity market. It consists of the smallest 2,000 companies included
in the Russell 3000
®
Index, which is composed of
the 3,000 largest U.S. companies as determined by market capitalization.
The top 5 industry groups by
market capitalization as of February 28, 2013 were: Financial Services, Consumer Discretionary, Producer Durables, Technology,
and Health Care.
|
|
The Hang Seng
®
Index
|
|
The HSI is a free float-adjusted market capitalization weighted stock market index in the Stock Exchange of Hong Kong Limited (the “SEHK”). The HSI is an indicator of the performance of the Hong Kong stock market. Only companies with a primary listing on the main board of the SEHK are eligible as constituents of the HSI.
|
|
For further information on each Reference Asset please see “Information
Relating to the Securities Linked to the EURO STOXX 50
®
Index”, “Information Relating to the Securities
Linked to the Russell 2000
®
Index”, “Information Relating to the Securities Linked to the Hang Seng
®
Index”, as applicable, on page FWP-13, FWP-14,or FWP-15, as applicable, and “The EURO STOXX 50
®
Index,”
“The Russell 2000
®
Index,” and “The Hang Seng
®
Index” in the accompanying
Equity Index Underlying Supplement. We have derived all disclosure regarding the Reference Assets from publicly available information.
Neither HSBC USA Inc. nor any of its affiliates have undertaken any independent review of, or made any due diligence inquiry with
respect to, the publicly available information about the Reference Assets.
HSBC USA
Inc.
Buffered Accelerated
Market Participation Securities
TM
(Buffered
AMPS)
|
|
EURO STOXX 50
®
Index
Russell 2000
®
Index
Hang Seng
®
Index
This free writing prospectus
relates to three offerings of Buffered Accelerated Market Participation Securities. Each of the three securities will have the
respective terms described in this free writing prospectus and the accompanying prospectus supplement, prospectus and relevant
underlying supplement. If the terms of the securities offered hereby are inconsistent with those described in the accompanying
prospectus supplement, prospectus or relevant underlying supplement, the terms described in this free writing prospectus shall
control.
You should be willing to forgo interest and dividend
payments during the term of the securities and, if the relevant Reference Return is negative, lose up to 90% of your principal.
This free writing prospectus
relates to multiple offerings of securities, each linked to the performance of a specific (each index, a “Reference Asset”).
Each of the three securities will have a different Maximum Cap. The performance of each of the three securities does not depend
on the performance of any of the other securities. The purchaser of a security will acquire a senior unsecured debt security of
HSBC USA Inc. linked to the relevant Reference Asset, as described below. The following key terms relate to the offerings of securities:
Issuer:
|
HSBC USA Inc.
|
Principal Amount:
|
$1,000 per security
|
Reference Asset:
|
The relevant underlying index, as indicated below
|
Reference Asset
|
Ticker
|
Upside Participation Rate
|
Maximum Cap
1
|
CUSIP/ISIN
|
|
EURO STOXX 50
®
Index
|
SX5E
|
200%
|
50% to 55%
|
40432XDA6/US40432XDA63
|
|
Russell 2000
®
Index
|
RTY
|
200%
|
30% to35%
|
40432XDB4/US40432XDB47
|
|
Hang Seng
®
Index
|
HSI
|
200%
|
25% to 30%
|
40432XDC2/US40432XDC20
|
|
1
Expected with respect to each offering of securities. The actual Maximum Cap for each offering of securities will be determined on the Pricing Date.
|
|
Trade Date:
|
April 19, 2013
|
Pricing Date:
|
April 19, 2013
|
Original Issue Date:
|
April 26, 2013
|
Final Valuation Date:
|
April 19, 2016, subject to adjustment as described under “Additional Terms of the Notes—Valuation Dates” in the relevant accompanying underlying supplement.
|
Maturity Date:
|
5 business days after the Final Valuation Date, and expected to be April 26, 2016. The Maturity Date is subject to adjustment as described under “Additional Terms of the Notes—Coupon Payment Dates, Call Payment Dates and Maturity Date” in the relevant accompanying underlying supplement.
|
Payment at Maturity:
|
On the Maturity Date, for each security, we will pay you the Final Settlement Value.
|
|
|
Reference Return:
|
With respect to each Reference Asset,
the quotient, expressed as a percentage, calculated as follows:
Final Value –
Initial Value
Initial Value
|
Final Settlement
Value:
|
If the relevant Reference Return
is greater than zero,
you will receive a cash payment on the Maturity Date, per $1,000 Principal Amount of securities,
equal to the lesser of:
(a) $1,000 + ($1,000 × Reference
Return × Upside Participation Rate); and
(b) $1,000 + ($1,000 × Maximum Cap).
If the relevant Reference Return
is less than or equal to zero but greater than or equal to the Buffer Value
, you will receive $1,000 per $1,000 Principal
Amount of securities (zero return).
If the relevant Reference Return
is less than the Buffer Value
,
you will receive a cash payment on the Maturity Date, per $1,000 Principal Amount of securities,
calculated as follows:
$1,000 + ($1,000 × (Reference
Return + 10%)).
|
|
Under these circumstances, you will lose
1% of the Principal Amount of your securities for each percentage point that the Reference Return is below the Buffer Value. For
example, if the Reference Return is -30%, you will suffer a 20% loss and receive 80% of the Principal Amount, subject to the credit
risk of HSBC.
If the Reference Return is less than the Buffer Value, you will lose up to 90% of your investment.
|
Buffer Value
|
With respect to each offering, -10%
|
Initial Value:
|
The Official Closing Level of the relevant Reference Asset on the Pricing Date.
|
Final Value:
|
The Official Closing Level of such Reference Asset on the Final Valuation Date.
|
Official Closing Level:
|
The closing level of the relevant Reference Asset on any scheduled trading day as determined by the calculation agent based upon the value displayed on the relevant Bloomberg Professional
®
service page (with respect to the SX5E, “SX5E <INDEX>”, with respect to the RTY, “RTY <INDEX>”, and with respect to the HSI, “HSI <INDEX>”, for each Reference Asset, any successor page on the Bloomberg Professional
®
service or any successor service, as applicable.
|
Form of Securities:
|
Book-Entry
|
Listing:
|
The securities will not be listed on any U.S. securities exchange or quotation system.
|
The Trade Date, the Pricing Date and the other dates set
forth above are subject to change, and will be set forth in the final pricing supplement relating to the securities.
GENERAL
This free writing prospectus relates to
three separate offerings of securities, each linked to a different Reference Asset identified on the cover page. The purchaser
of a security will acquire a senior unsecured debt security of HSBC USA Inc. linked to a single Reference Asset. We reserve the
right to withdraw, cancel or modify any offering and to reject orders in whole or in part. Although each offering of securities
relates to a Reference Asset identified on the cover page, you should not construe that fact as a recommendation as to the merits
of acquiring an investment linked to such Reference Asset or any component security included in such Reference Asset or as to the
suitability of an investment in the securities.
You should read this document together
with the prospectus dated March 22, 2012, the prospectus supplement dated March 22, 2012 and the Equity Index Underlying Supplement
dated March 22, 2012. If the terms of the securities offered hereby are inconsistent with those described in the accompanying prospectus
supplement, prospectus, or relevant underlying supplement, the terms described in this free writing prospectus shall control. You
should carefully consider, among other things, the matters set forth in “Risk Factors” beginning on page FWP-8 of this
free writing prospectus, page S-3 of the prospectus supplement and page S-1 of the Equity Index Underlying Supplement, as the securities
involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting
and other advisors before you invest in the securities. As used herein, references to the “Issuer”, “HSBC”,
“we”, “us” and “our” are to HSBC USA Inc.
HSBC has filed a registration statement
(including a prospectus, a prospectus supplement and underlying supplements) with the SEC for the offerings to which this free
writing prospectus relates. Before you invest, you should read the prospectus, prospectus supplement and relevant underlying supplement
in that registration statement and other documents HSBC has filed with the SEC for more complete information about HSBC and these
offerings. You may get these documents for free by visiting EDGAR on the SEC’s web site at www.sec.gov. Alternatively, HSBC
Securities (USA) Inc. or any dealer participating in these offerings will arrange to send you the prospectus, prospectus supplement
and relevant underlying supplement if you request them by calling toll-free 1-866-811-8049.
You may also obtain:
We are using this free writing prospectus
to solicit from you an offer to purchase the securities. You may revoke your offer to purchase the securities at any time prior
to the time at which we accept your offer by notifying HSBC Securities (USA) Inc. We reserve the right to change the terms of,
or reject any offer to purchase, the securities prior to their issuance. In the event of any material changes to the terms of the
securities, we will notify you.
PAYMENT AT MATURITY
On the Maturity Date, for each security
you hold, we will pay you the Final Settlement Value, which is an amount in cash, as described below:
If the relevant Reference Return is
greater than zero
, you will receive a cash payment on the Maturity Date, per $1,000 Principal Amount of securities, equal to
the lesser of:
(a) $1,000 + ($1,000 × Reference
Return × Upside Participation Rate); and
(b) $1,000 + ($1,000 × Maximum
Cap).
If the relevant Reference Return is
less than or equal to zero but greater than or equal to the Buffer Value,
you will receive $1,000 per $1,000 Principal Amount
of securities (zero return).
If the relevant Reference Return is
less than the Buffer Value,
you will receive a cash payment on the Maturity Date, per $1,000 Principal Amount of securities,
calculated as follows:
$1,000 + ($1,000 ×
(Reference Return + 10%)).
Under these circumstances, you will lose
1% of the Principal Amount of your securities for each percentage point that the Reference Return is below the Buffer Value. For
example, if the Reference Return is -30%, you will suffer a 20% loss and receive 80% of the Principal Amount, subject to the credit
risk of HSBC.
You should be aware that if the relevant Reference Return is less than the Buffer Value, you will lose up to 90%
of your investment.
Interest
The securities will not pay interest.
Calculation Agent
We or one of our affiliates will act as
calculation agent with respect to the securities.
Reference Sponsor
With respect to securities linke
d
to the SX5E, Deutsche Börse AG and SIX Group AG are the reference sponsors. With respect to securities linked to the RTY,
the Russell Investment Gr
oup is the reference sponsor. With respect to securities linked to the HSI, Hang Seng Indexes Company
Limited, a wholly-owned subsidiary of Hang Seng Bank, is the reference sponsor.
INVESTOR SUITABILITY
The securities may be suitable for
you if:
|
}
|
You seek an investment with an enhanced return linked to the potential positive performance of
the relevant Reference Asset and you believe the value of such Reference Asset will increase over the term of the securities.
|
|
}
|
You are willing to invest in the securities based on the Maximum Cap indicated herein with respect
to that security offering, which may limit your return at maturity. The actual Maximum Cap for each offering of securities will
be determined on the Pricing Date.
|
|
}
|
You are willing to make an investment that is exposed to the negative Reference Return on a 1-to-1
basis for each percentage point that the relevant Reference Return is less than -10%.
|
|
}
|
You are willing to accept the risk and return profile of the securities versus a conventional debt
security with a comparable maturity issued by HSBC or another issuer with a similar credit rating.
|
|
}
|
You are willing to forego dividends or other distributions paid to holders of the stocks comprising
the relevant Reference Asset.
|
|
}
|
You do not seek current income from your investment.
|
|
}
|
You do not seek an investment for which there is an active secondary market.
|
|
}
|
You are willing to hold the securities to maturity.
|
|
}
|
You are comfortable with the creditworthiness of HSBC, as Issuer of the securities.
|
The securities may not be suitable
for you if:
|
}
|
You believe the relevant Reference Return will be negative on the Final Valuation Date or that
the relevant Reference Return will not be sufficiently positive to provide you with your desired return.
|
|
}
|
You are unwilling to invest in the securities based on the Maximum Cap indicated herein with respect
to that security offering, which may limit your return at maturity. The actual Maximum Cap for each offering of securities will
be determined on the Pricing Date.
|
|
}
|
You are unwilling to make an investment that is exposed to the negative Reference Return on a 1-to-1
basis for each percentage point that the relevant Reference Return is less than -10%.
|
|
}
|
You seek an investment that provides full return of principal.
|
|
}
|
You prefer the lower risk, and therefore accept the potentially lower returns, of conventional
debt securities with comparable maturities issued by HSBC or another issuer with a similar credit rating.
|
|
}
|
You prefer to receive the dividends or other distributions paid on the stocks comprising the relevant
Reference Asset.
|
|
}
|
You seek current income from your investment.
|
|
}
|
You seek an investment for which there will be an active secondary market.
|
|
}
|
You are unable or unwilling to hold the securities to maturity.
|
|
}
|
You are not willing or are unable to assume the credit risk associated with HSBC, as Issuer of
the securities.
|
RISK FACTORS
We urge you to read the section “Risk
Factors” beginning on page S-3 in the accompanying prospectus supplement and page S-1 of the Equity Index Underlying
Supplement. Investing in the securities is not equivalent to investing directly in any of the stocks comprising the relevant Reference
Asset. You should understand the risks of investing in the securities and should reach an investment decision only after careful
consideration, with your advisors, of the suitability of the securities in light of your particular financial circumstances and
the information set forth in this free writing prospectus and the accompanying prospectus supplement, prospectus and relevant underlying
supplement.
In addition to the risks discussed below,
you should review “Risk Factors” in the accompanying prospectus supplement and relevant underlying supplement including
the explanation of risks relating to the securities described in the following sections:
|
}
|
“—Risks Relating to All Note Issuances” in the prospectus supplement;
|
|
}
|
“—General Risks Related to Indices” in the Equity Index Underlying Supplement;
|
If your securities are linked to the
RTY:
|
}
|
“—Small-Capitalization Or Mid-Capitalization Companies Risk” in the Equity Index
Underlying Supplement.
|
If your securities are linked to the
SX5E or HSI:
|
}
|
“—Securities Prices Generally Are Subject to Political, Economic, Financial and Social
Factors That Apply to the Markets in Which They Trade and, to a Lesser Extent, Foreign Markets” in the Equity Index Underlying
Supplement;
|
|
}
|
“—Time Differences Between the Domestic and Foreign Markets and New York City May Create
Discrepancies in the Trading Level or Price of the Notes” in the Equity Index Underlying Supplement.
|
You will be subject to
significant risks not associated with conventional fixed-rate or floating-rate debt securities.
Your investment in the securities
may result in a loss.
You will be exposed to the decline in the
Final Value from the Initial Value beyond the Buffer Value of -10%. Accordingly, if the relevant Reference Return is less than
-10%, your Payment at Maturity will be less than the Principal Amount of your securities. You may lose up to 90% of your investment
at maturity if the relevant Reference Return is negative.
The appreciation on the securities
is limited by the relevant Maximum Cap.
You will not participate in any appreciation
in the value of the relevant Reference Asset (as multiplied by the Upside Participation Rate) beyond the relevant Maximum Cap.
The Maximum Cap (to be determined on the Pricing Date) will not be less than 50% or greater than 55% with respect to the securities
linked to the SX5E, will not be less than 30% or greater than 35% with respect to the securities linked to the RTY, and will not
be less than 25% or greater than 30% with respect to the securities linked to the HSI. You will not receive a return on the securities
greater than the relevant Maximum Cap.
The amount payable on the securities is not linked to the
level of the relevant Reference Asset at any time other than on the Final Valuation Date.
The Final Level will be based on the Official
Closing Level of the relevant Reference Asset on the Final Valuation Date, subject to postponement for non-trading days and certain
market disruption events. Even if the level of the relevant Reference Asset appreciates prior to the Final Valuation Date but then
decreases on the Final Valuation Date to a level that is below the Initial Level, the Payment at Maturity will be less, and may
be significantly less, than it would have been had the Payment at Maturity been linked to the level of the relevant Reference Asset
prior to such decrease. Although the actual level of the relevant Reference Asset on the Maturity Date or at other times during
the term of the securities may be higher than the Final Level, the Payment at Maturity will be based solely on the Official Closing
Level of the relevant Reference Asset on the Final Valuation Date.
Credit risk of HSBC USA Inc.
The securities are senior unsecured debt
obligations of the Issuer, HSBC, and are not, either directly or indirectly, an obligation of any third party. As further described
in the accompanying prospectus supplement and prospectus, the securities will rank on par with all of the other unsecured and unsubordinated
debt obligations of HSBC, except such obligations as may be preferred by operation of law. Any payment to be made on the securities,
including any return of principal at maturity, depends on the ability of HSBC to satisfy its obligations as they come due. As a
result, the actual and perceived creditworthiness of HSBC may affect the market value of the securities and, in the event HSBC
were to default on its obligations, you may not receive the amounts owed to you under the terms of the securities.
The securities will not bear interest.
As a holder of the securities, you will
not receive interest payments.
Changes that affect the relevant Reference
Asset will affect the market value of the securities and the amount you will receive at maturity.
The policies of the reference sponsor of
the relevant Reference Asset concerning additions, deletions and substitutions of the constituents comprising such Reference Asset
and the manner in which the reference sponsor takes account of certain changes affecting those constituents included in such Reference
Asset may affect the value of such Reference Asset. The policies of the reference sponsor with respect to the calculation of the
relevant Reference Asset could also affect the value of such Reference Asset. The reference sponsor may discontinue or suspend
calculation or dissemination of its relevant Reference Asset. Any such actions could affect the value of the securities.
Small-capitalization risk
.
The RTY tracks companies that may be considered
small-capitalization companies. These companies often have greater stock price volatility, lower trading volume and less liquidity
than large-capitalization companies and therefore the respective index level may be more volatile than an investment in stocks
issued by larger companies. Stock prices of small-capitalization companies may also be more vulnerable than those of larger companies
to adverse business and economic developments, and the stocks of small-capitalization companies may be thinly traded, making it
difficult for the RTY to track them. In addition, small-capitalization companies are often less stable financially than large-capitalization
companies and may depend on a small number of key personnel, making them more vulnerable to loss of personnel. Small-capitalization
companies are often subject to less analyst coverage and may be in early, and less predictable, periods of their corporate existences.
These companies tend to have smaller revenues, less diverse product lines, smaller shares of their product or service markets,
fewer financial resources and competitive strengths than large-capitalization companies, and are more susceptible to adverse developments
related to their products.
Risks
associated with non-U.S. companies.
The values of the SX5E and the HSI depends
upon the stocks of non-U.S. companies, and thus involve risks associated with the home countries of those non-U.S. companies. The
prices of these non-U.S. stocks may be affected by political, economic, financial and social
factors in the home country of each applicable
company, including changes in that country’s government, economic and fiscal policies, currency exchange laws or other laws
or restrictions, which could affect the value of the securities. These foreign securities may have less liquidity and could be
more volatile than many of the securities traded in U.S. or other securities markets. Direct or indirect government intervention
to stabilize the relevant foreign securities markets, as well as cross shareholdings in foreign companies, may affect trading levels
or prices and volumes in those markets. The other special risks associated with foreign securities may include, but are not limited
to: less liquidity and smaller market capitalizations; less rigorous regulation of securities markets; different accounting and
disclosure standards; governmental interference; currency fluctuations; higher inflation; and social, economic and political uncertainties.
These factors may adversely affect the performance of the SX5E or the HSI and, as a result, the value of the securities.
The
securities will not be adjusted for changes in exchange rates.
Although
the equity securities held by the SX5E and the HSI are traded in currencies other than U.S. dollars, and your securities are denominated
in U.S. dollars, the amount payable on your securities at maturity, if any, will not be adjusted for changes in the exchange rates
between the U.S. dollar and the currencies in which these non-U.S. equity securities are denominated. Changes in exchange rates,
however, may also reflect changes in the applicable non-U.S. economies that in turn may affect the value of the SX5E or the HSI,
and therefore your securities. The amount we pay in respect of your securities on the maturity date, if any, will be determined
solely in accordance with the procedures described in this free writing prospectus.
The securities are not insured by
any governmental agency of the United States or any other jurisdiction.
The securities are not deposit liabilities
or other obligations of a bank and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency
or program of the United States or any other jurisdiction. An investment in the securities is subject to the credit risk of HSBC,
and in the event that HSBC is unable to pay its obligations as they become due, you may not receive the full Payment at Maturity
of the securities.
Certain built-in costs are likely
to adversely affect the value of the securities prior to maturity.
While the Payment at Maturity described
in this free writing prospectus is based on the full Principal Amount of your securities, the original issue price of the securities
includes the agent’s commission and the estimated cost of HSBC hedging its obligations under the securities. As a result,
the price, if any, at which HSBC Securities (USA) Inc. will be willing to purchase securities from you in secondary market transactions,
if at all, will likely be lower than the original issue price, and any sale prior to the Maturity Date could result in a substantial
loss to you. The securities are not designed to be short-term trading instruments. Accordingly, you should be able and willing
to hold your securities to maturity.
The securities lack liquidity.
The securities will not be listed on any
securities exchange. HSBC Securities (USA) Inc. is not required to offer to purchase the securities in the secondary market, if
any exists. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the securities
easily. Because other dealers are not likely to make a secondary market for the securities, the price at which you may be able
to trade your securities is likely to depend on the price, if any, at which HSBC Securities (USA) Inc. is willing to buy the securities.
Potential conflicts of interest may
exist.
HSBC and its affiliates play a variety
of roles in connection with the issuance of the securities, including acting as calculation agent and hedging our obligations under
the securities. In performing these duties, the economic interests of the calculation agent and other affiliates of ours are potentially
adverse to your interests as an investor in the securities. We will not have any obligation to consider your interests as a holder
of the securities in taking any action that might affect the value of your securities.
Uncertain tax treatment.
For a discussion of the U.S. federal income
tax consequences of your investment in a security, please see the discussion under “U.S. Federal Income Tax Considerations”
herein and the discussion under “U.S. Federal Income Tax Considerations” in the accompanying prospectus supplement.
ILLUSTRATIVE EXAMPLES
The following table and examples are provided
for illustrative purposes only and are hypothetical. They do not purport to be representative of every possible scenario concerning
increases or decreases in the value of the relevant Reference Asset relative to its Initial Value. We cannot predict the Final
Value of the relevant Reference Asset. The assumptions we have made in connection with the illustrations set forth below may not
reflect actual events. You should not take this illustration or these examples as an indication or assurance of the expected performance
of the relevant Reference Asset to which your securities are linked or the return on your securities
.
With respect to the
securities, the Final Settlement Value may be less than the amount that you would have received from a conventional debt security
with the same stated maturity, including those issued by HSBC. The numbers appearing in the table below and following examples
have been rounded for ease of analysis.
The table below illustrates the Payment
at Maturity on a $1,000 investment in the securities for a hypothetical range of Reference Returns from -100% to +100%. The following
results are based solely on the assumptions outlined below. The “Hypothetical Return on the Security” as used below
is the number, expressed as a percentage, that results from comparing the Payment at Maturity per $1,000 Principal Amount of securities
to $1,000. The potential returns described here assume that your securities are held to maturity. You should consider carefully
whether the securities are suitable to your investment goals. The following table and examples assume the following:
}
|
Principal Amount:
|
$1,000
|
}
|
Upside Participation Rate:
|
200%
|
}
|
Hypothetical Maximum Cap:
|
25% (The actual Maximum Cap for each offering of securities will be determined on the Pricing Date and with respect to the securities linked to the SX5E will not be less than 50% or greater than 55%, with respect to the securities linked to the RTY will not be less than 30% or greater than 35%, and with respect to the securities linked to the HSI will not be less than 25% or greater than 30%).
|
Hypothetical
Reference Return
|
Hypothetical Payment
at Maturity
|
Hypothetical Return on
the Security
|
100.00%
|
$1,250.00
|
25.00%
|
80.00%
|
$1,250.00
|
25.00%
|
60.00%
|
$1,250.00
|
25.00%
|
40.00%
|
$1,250.00
|
25.00%
|
20.00%
|
$1,250.00
|
25.00%
|
12.50%
|
$1,250.00
|
25.00%
|
10.00%
|
$1,200.00
|
20.00%
|
5.00%
|
$1,100.00
|
10.00%
|
2.00%
|
$1,040.00
|
4.00%
|
1.00%
|
$1,020.00
|
2.00%
|
0.00%
|
$1,000.00
|
0.00%
|
-1.00%
|
$1,000.00
|
0.00%
|
-2.00%
|
$1,000.00
|
0.00%
|
-5.00%
|
$1,000.00
|
0.00%
|
-10.00%
|
$1,000.00
|
0.00%
|
-15.00%
|
$950.00
|
-5.00%
|
-20.00%
|
$900.00
|
-10.00%
|
-30.00%
|
$800.00
|
-20.00%
|
-40.00%
|
$700.00
|
-30.00%
|
-60.00%
|
$500.00
|
-50.00%
|
-80.00%
|
$300.00
|
-70.00%
|
-100.00%
|
$100.00
|
-90.00%
|
The following examples indicate how the
Final Settlement Value would be calculated with respect to a hypothetical $1,000 investment in the securities.
Example 1: The relevant Reference Return
is 2.00%.
|
|
Reference Return:
|
2.00%
|
Final Settlement Value:
|
$1,040.00
|
Because the relevant Reference Return is
positive, and such Reference Return multiplied by the Upside Participation Rate is less than the hypothetical Maximum Cap, the
Final Settlement Value would be $1,040.00 per $1,000 Principal Amount of securities, calculated as follows:
$1,000 + ($1,000 × Reference
Return × Upside Participation Rate)
= $1,000 + ($1,000 × 2.00% ×
200%)
= $1,040.00
Example 1 shows that you will receive the
return of your principal investment plus a return equal to the relevant Reference Return multiplied by 200% when such Reference
Return is positive and, as multiplied by the Upside Participation Rate, equal to or less than the relevant Maximum Cap.
Example 2: The relevant Reference Return
is 20.00%.
|
|
Reference Return:
|
20.00%
|
Final Settlement Value:
|
$1,250.00
|
Because the relevant Reference Return is
positive, and such Reference Return multiplied by the Upside Participation Rate is greater than the hypothetical Maximum Cap, the
Final Settlement Value would be $1,250.00 per $1,000 Principal Amount of securities, calculated as follows:
$1,000 + ($1,000 × Maximum Cap)
= $1,000 + ($1,000 × 25.00%)
= $1,250.00
Example 2 shows that you will receive the
return of your principal investment plus a return equal to the Maximum Cap when the relevant Reference Return is positive and such
Reference Return multiplied by 200% exceeds the relevant Maximum Cap.
Example 3: The relevant Reference Return
is -5.00%.
|
|
Reference Return:
|
-5.00%
|
Final Settlement Value:
|
$1,000.00
|
Because the relevant Reference Return is
less than zero but greater than the Buffer Value of -10%, the Final Settlement Value would be $1,000.00 per $1,000 Principal Amount
of securities (a zero return).
Example 3 shows that you will receive the
return of your principal investment where the value of the relevant Reference Asset declines by no more than 10% over the term
of the securities.
Example 4: The relevant Reference Return
is -30.00%.
|
|
Reference Return:
|
-30.00%
|
Final Settlement Value:
|
$800.00
|
|
|
|
Because the relevant Reference Return is
less than the Buffer Value of -10%, the Final Settlement Value would be $800.00 per $1,000 Principal Amount of securities, calculated
as follows:
$1,000 + ($1,000 × (Reference
Return + 10%))
= $1,000 + ($1,000 × (-30.00%
+ 10%))
= $800.00
Example 4 shows that you are exposed on a
1-to-1 basis to declines in the value of the relevant Reference Asset beyond the Buffer Value of -10%. YOU MAY LOSE UP TO 90% OF
THE PRINCIPAL AMOUNT OF YOUR SECURITIES.
INFORMATION RELATING TO THE SECURITIES
LINKED TO THE EURO STOXX 50
®
INDEX
The disclosure
relating to the SX5E contained below relates only to the offering of securities linked to the SX5E.
Description of the SX5E
The SX5E is composed of 50 stocks from
the Eurozone (Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, the Netherlands, Portugal and Spain)
portion of the STOXX Europe 600 Supersector indices. The STOXX Europe 600 Supersector indices contain the 600 largest stocks traded
on the major exchanges of 18 European countries and are organized into the following 19 Supersectors: automobiles & parts;
banks; basic resources; chemicals; construction & materials; financial services; food & beverage; health care; industrial
goods & services; insurance; media; oil & gas; personal & household goods; real estate; retail; technology; telecommunications;
travel & leisure and utilities.
For more information
about the SX5E, see “The EURO STOXX 50
®
Index” beginning on page S-40 of the accompanying Equity Index
Underlying Supplement.
|
Historical Performance of the SX5E
The following graph sets forth the historical
performance of the SX5E based on the daily historical closing levels from March 26, 2008 through March 26, 2013. The closing level
for the SX5E
on March 26, 2013 was 2,641.12. We obtained the closing levels below rom the Bloomberg Professional
®
service. We have not undertaken any independent review of, or made any due diligence inquiry with respect to, the information obtained
from the Bloomberg Professional
®
service.
|
The historical levels
of the SX5E should not be taken as an indication of future performance, and no assurance can be given as to the Official Closing
Level of the SX5E on the Final Valuation Date.
INFORMATION RELATING TO THE SECURITIES
LINKED TO THE RUSSELL 2000
®
INDEX
The disclosure relating
to the RTY contained below relates only to the offering of securities linked to the RTY.
|
|
Description of the RTY
The RTY is designed to track the performance
of the small capitalization segment of the United States equity market. All 2,000 stocks are traded on the New York Stock Exchange
or NASDAQ, and the RTY consists of the smallest 2,000 companies included in the Russell 3000
®
Index. The Russell
3000
®
Index is composed of the 3,000 largest United States companies as determined by market capitalization and
represents approximately 98% of the United States equity market.
The
top 5 industry groups by market capitalization as of February 28, 2013 were: Financial Services,
Consumer
Discretionary, Producer Durables, Technology, and Health Care.
For
more information about the RTY, see “The Russell 2000
Ò
Index” beginning on page S-21 of the accompanying Equity Index Underlying Supplement.
|
Historical Performance of the RTY
The
following graph sets forth the historical performance of the RTY based on the daily historical closing levels from March 26, 2008
through
March 26, 2013. The closing level for the RTY on March 26,
2013 was 949.82. We obtained the closing levels below from the Bloomberg Professional
®
service. We have not undertaken
any independent review of, or made any due diligence inquiry with respect to, the information obtained from the Bloomberg Professional
®
service.
|
The
historical levels of the RTY should not be taken as an indication of future performance, and no assurance can be given as to the
Official Closing Level of the RTY on the Final Valuation Date.
INFORMATION RELATING TO THE SECURITIES
LINKED TO THE HANG SENG
®
INDEX
The disclosure relating
to the HSI contained below relates only to the offering of securities linked to the HSI.
Description of the HSI
The HSI is a free float-adjusted market
capitalization weighted stock market index in the Stock Exchange of Hong Kong Limited (the “SEHK”). The HSI is an indicator
of the performance of the Hong Kong stock market. Only companies with a primary listing on the main board of the SEHK are eligible
as constituents of the HSI.
For more information
about the HSI, see “The Hang Seng
®
Index” beginning on page S-30 of the Equity Index Underlying Supplement.
|
Historical Performance of the HSI
The following
graph sets forth the historical performance of the HSI based on the daily historical closing levels from March 26, 2008 through
March 26, 2013. The closing level for the HSI on March 26, 2013 was 22,311.08. We obtained the closing levels below from the Bloomberg
Professional
®
service. We have not undertaken any independent review of, or made any due diligence inquiry with
respect to, the information obtained from the Bloomberg Professional
®
service.
|
The historical levels of the HSI should not be taken as an indication of future performance, and no assurance can be given as to the Official Closing Level of the HSI on the Final Valuation Date.
|
SUPPLEMENTAL PLAN OF DISTRIBUTION
(CONFLICTS OF INTEREST)
We have appointed HSBC Securities (USA)
Inc., an affiliate of HSBC, as the agent for the sale of the securities. Pursuant to the terms of a distribution agreement, HSBC
Securities (USA) Inc. will purchase the securities from HSBC at the price to public less the underwriting discount set forth on
the cover page of the pricing supplement to which this free writing prospectus relates, for distribution to other registered broker-dealers,
or will offer the securities directly to investors. HSBC Securities (USA) Inc. proposes to offer the securities at the price to
public set forth on the cover page of this free writing prospectus. HSBC USA Inc. or one of our affiliates may pay varying underwriting
discounts of up to 2.15% per $1,000 Principal Amount of securities in connection with the distribution of the securities to other
registered broker-dealers.
An affiliate of HSBC has paid or may pay
in the future an amount to broker-dealers in connection with the costs of the continuing implementation of systems to support the
securities.
In addition, HSBC Securities (USA) Inc.
or another of its affiliates or agents may use the pricing supplement to which this free writing prospectus relates in market-making
transactions after the initial sale of the securities, but is under no obligation to do so and may discontinue any market-making
activities at any time without notice.
We expect that delivery of the securities
will be made against payment for the securities on or about the Original Issue Date set forth on the inside cover page of this
document, which is expected to be the fifth business day following the Trade Date of the securities. Under Rule 15c6-1 under
the Securities Exchange Act of 1934, trades in the secondary market generally are required to settle in three business days, unless
the parties to that trade expressly agree otherwise. Accordingly, purchasers who wish to trade securities on the Trade Date
and the following business day thereafter will be required to specify an alternate settlement cycle at the time of any such trade
to prevent a failed settlement, and should consult their own advisors.
See “Supplemental Plan of Distribution
(Conflicts of Interest)” on page S-49 in the prospectus supplement.
U.S. FEDERAL INCOME TAX CONSIDERATIONS
There is no direct legal authority as to
the proper tax treatment of the securities, and therefore significant aspects of the tax treatment of the securities are uncertain
as to both the timing and character of any inclusion in income in respect of the securities. Under one approach, a security should
be treated as a pre-paid executory contract with respect to the relevant Reference Asset. We intend to treat the securities consistent
with this approach. Pursuant to the terms of the securities, you agree to treat the securities under this approach for all U.S.
federal income tax purposes. Subject to the limitations described therein, and based on certain factual representations received
from us, in the opinion of our special U.S. tax counsel, Morrison & Foerster LLP, it is reasonable to treat a security as a
pre-paid executory contract with respect to the relevant Reference Asset. Pursuant to this approach, we do not intend to report
any income or gain with respect to the securities prior to their maturity or an earlier sale or exchange and we intend to treat
any gain or loss upon maturity or an earlier sale or exchange as long-term capital gain or loss, provided that you have held the
security for more than one year at such time for U.S. federal income tax purposes.
We will not attempt to ascertain whether
any of the entities whose stock is included in, or owned by, the relevant Reference Asset, as the case may be, would be treated
as a passive foreign investment company (“PFIC”) or United States real property holding corporation (“USRPHC”),
both as defined for U.S. federal income tax purposes. If one or more of the entities whose stock is included in, or owned by, the
relevant Reference Asset, as the case may be, were so treated, certain adverse U.S. federal income tax consequences might apply.
You should refer to information filed with the SEC and other authorities by the entities whose stock is included in, or owned by,
the relevant Reference Asset, as the case may be, and consult your tax advisor regarding the possible consequences to you if one
or more of the entities whose stock is included in, or owned by, the relevant Reference Asset, as the case may be, is or becomes
a PFIC or a USRPHC.
Withholding and reporting requirements
under the legislation enacted on March 18, 2010 (as discussed beginning on page S-48 of the prospectus supplement) will generally
apply to payments made after December 31, 2013. However, this withholding tax will not be imposed on payments pursuant to obligations
outstanding on January 1, 2014. Holders are urged to consult with their own tax advisors regarding the possible implications of
this recently enacted legislation on their investment in the securities.
For a discussion of the U.S. federal income
tax consequences of your investment in a security, please see the discussion under “U.S Federal Income Tax Considerations”
in the accompanying prospectus supplement.
|
|
|
TABLE OF CONTENTS
|
|
You should only rely on the
information contained in this free writing prospectus, any accompanying underlying supplement, prospectus supplement and prospectus.
We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this
free writing prospectus, any accompanying underlying supplement, prospectus supplement and prospectus. If anyone provides you with
different or inconsistent information, you should not rely on it. This free writing prospectus, any accompanying underlying supplement,
prospectus supplement and prospectus are not an offer to sell these securities, and these documents are not soliciting an offer
to buy these securities, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances,
assume that the information in this free writing prospectus, any accompanying underlying supplement, prospectus supplement and
prospectus is correct on any date after their respective dates.
HSBC USA Inc.
$
Buffered Accelerated Market
Participation Securities Linked to
the EURO STOXX 50
®
Index
$
Buffered Accelerated Market
Participation Securities Linked to
the Russell 2000
®
Index
$
Buffered Accelerated Market
Participation Securities Linked to
the Hang Seng
®
Index
April
1, 2013
FREE
WRITING PROSPECTUS
|
Free Writing Prospectus
|
|
General
|
FWP-6
|
Payment at Maturity
|
FWP-7
|
Investor Suitability
|
FWP-8
|
Risk Factors
|
FWP-8
|
Illustrative Examples
|
FWP-11
|
Information Relating to the Securities Linked to the EURO STOXX 50
®
Index
|
FWP-13
|
Information Relating to the Securities Linked to the Russell 2000
Ò
Index
|
FWP-14
|
Information Relating to the Securities Linked to the Hang Seng
®
Index
|
FWP-15
|
Supplemental Plan of Distribution (Conflicts of Interest)
|
FWP-16
|
U.S. Federal Income Tax Considerations
|
FWP-16
|
|
|
Equity Index Underlying Supplement
|
|
Risk Factors
|
S-1
|
The S&P 500
®
Index
|
S-6
|
The S&P 100
®
Index
|
S-10
|
The S&P MidCap 400
®
Index
|
S-14
|
The S&P 500 Low Volatility Index
|
S-18
|
The Russell 2000
®
Index
|
S-21
|
The Dow Jones Industrial Average
SM
|
S-25
|
The Hang Seng China Enterprises Index
®
|
S-27
|
The Hang Seng
®
Index
|
S-30
|
The Korea Stock Price Index 200
|
S-33
|
MSCI Indices
|
S-36
|
The EURO STOXX 50
®
Index
|
S-40
|
The PHLX Housing Sector
SM
Index
|
S-42
|
The TOPIX
®
Index
|
S-46
|
The NASDAQ-100 Index
®
|
S-49
|
S&P BRIC 40 Index
|
S-53
|
The Nikkei 225 Index
|
S-56
|
The FTSE™ 100 Index
|
S-58
|
Other Components
|
S-60
|
Additional Terms of the Notes
|
S-60
|
|
|
|
|
Prospectus Supplement
|
|
Risk Factors
|
S-3
|
Risks Relating to Our Business
|
S-3
|
Risks Relating to All Note Issuances
|
S-3
|
Pricing Supplement
|
S-7
|
Description of Notes
|
S-8
|
Use of Proceeds and Hedging
|
S-30
|
Certain ERISA Considerations
|
S-30
|
U.S. Federal Income Tax Considerations
|
S-32
|
Supplemental Plan of Distribution (Conflicts of Interest)
|
S-49
|
|
|
Prospectus
|
|
About this Prospectus
|
1
|
Risk Factors
|
1
|
Where You Can Find More Information
|
1
|
Special Note Regarding Forward-Looking Statements
|
2
|
HSBC USA Inc.
|
3
|
Use of Proceeds
|
3
|
Description of Debt Securities
|
3
|
Description of Preferred Stock
|
15
|
Description of Warrants
|
21
|
Description of Purchase Contracts
|
25
|
Description of Units
|
28
|
Book-Entry Procedures
|
30
|
Limitations on Issuances in Bearer Form
|
35
|
U.S. Federal Income Tax Considerations Relating to Debt Securities
|
35
|
Plan of Distribution (Conflicts of Interest)
|
51
|
Notice to Canadian Investors
|
53
|
Notice to EEA Investors
|
58
|
Certain ERISA Matters
|
59
|
Legal Opinions
|
60
|
Experts
|
60
|
Trimol (CE) (USOTC:TMOL)
Historical Stock Chart
From May 2024 to Jun 2024
Trimol (CE) (USOTC:TMOL)
Historical Stock Chart
From Jun 2023 to Jun 2024